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Carriage	 of	 the	New	Delhi	metallo-β-lactamase variant 1 
(NDM-1)	enables	drug	 resistance	 to	move	between	com-
munities and hospitals. In Bangladesh, we found the blaNDM-1 
gene	in	62%	of	environmental	waters	and	in	fermentative	
and nonfermentative gram-negative bacteria. Escherichia 
coli	 sequence	 type	 (ST)	 101	was	most	 commonly	 found,	
reflecting	 a	 common	 global	 relationship	 between	 ST101	
and	NDM-1.
Carbapenemases, bacterial enzymes that typically in-activate most of the β-lactam class of antimicrobial 
drugs, have emerged rapidly over the past decade (1). 
These resistance mechanisms are often accompanied by 
other resistance alleles, and together they can confer ex-
tensive drug resistance, leaving minimal treatment options 
(2). The New Delhi metallo-β-lactamase variant 1 (NDM-
1), a chimera formed by the fusion of 2 resistance genes, is 
unique among the carbapenemases (3). Since its descrip-
tion in 2009, NDM-1 has spread rapidly to many countries 
worldwide and appears to be endemic in South Asia (1,4,5). 
A study of the environment in New Delhi, India, showed 
that ≈30% of surface waters and sewage was contaminated 
with NDM-1; the enzyme was also detected in drinking wa-
ter (6). In addition, high rates of NDM-1 gut carriage have 
been found in the community and in hospitals in Pakistan 
(7). High rates of gut carriage can lead to contamination 
of drinking water and food through inadequate sewage 
treatment. Furthermore, gut carriage of NDM-1–encoding 
Escherichia coli can lead to common community-acquired 
infections (e.g., urinary tract infections), which often re-
quire hospitalization (8) and enable resistance mechanisms 
to move between community and hospital sectors. Indirect 
studies in 2009 and 2010 showed that NDM-1 was not 
present in the Bangladesh environment (9,10). To deter-
mine whether NDM-1 is now present in Bangladesh, we 
surveyed the environmental waters of Dhaka. 
The Study
During October 19–27, 2012, we collected environmental 
water/sewage samples from 7 regions (58 sites) in Dhaka, 
Bangladesh (Figure 1). Control samples were from the United 
Kingdom. Each sample was investigated for bacterial growth 
on UTI brilliance agar plates (Thermo Fischer Scientific, 
Basingstoke, UK) containing vancomycin (30 mg/L) plus 
meropenem (0.5 mg/L). The species of individual colonies 
of different colors and morphologies were determined by us-
ing matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry. Bacteria were genetically characterized 
by blaNDM-specific PCR. Genetic location of the blaNDM-1 gene 
was determined by probing S1 nuclease pulsed-field gels. A 
subset of isolates of each species was further investigated 
for MICs of relevant antimicrobial drugs. All E. coli isolates 
were genotyped to determine multilocus sequence typing 
group; examples of each group were characterized for addi-
tional relevant resistance mechanisms. Details are provided 
in the online Technical Appendix (http://wwwnc.cdc.gov/
EID/article/21/6/14-1578-Techapp1.pdf).
The carbapenemase and extended-spectrum 
β-lactamase genes bla
NDM-1
 and bla
CTX-M-15
 were detected 
by PCR in 36 (62%) and 41 (71%), respectively, of the 58 
water samples. Both genes were found at all 7 sample re-
gion sites in Dhaka. Gene bla
CTX-M-15
, but not bla
NDM-1
, was 
detected in sewage samples from the United Kingdom; 
neither was detected in UK water samples from the 
River Thames.
We identified 226 gram-negative NDM-1–producing 
isolates to the species level (Figure 1; online Technical Ap-
pendix Table 1); 15 isolates harboring bla
NDM-1
 could not 
be identified and were not investigated further. The most 
widely disseminated bacteria in samples from Dhaka were 
pseudomonads (6/7 regions) and Klebsiella pneumoniae 
(4/7 regions). Nine different species of Pseudomonas spp. 
and 5 Acinetobacter spp., mostly belonging to nonpatho-
genic strains, were among the nonfermentative bacteria 
(online Technical Appendix Table 1). Carbapenem resis-
tance in the Pseudomonas spp. isolates was unstable; all 
strains lost the bla
NDM-1
 gene after 2 days’ growth or when 
frozen for storage.
With the exception of 4 isolates, all bacterial isolates 
contained the original bla
NDM-1
 allele; 3 E. coli sequence 
type (ST) 101 isolates carried the blaNDM-3 variant, and 1 
ST648 isolate carried the bla
NDM-4
 variant (online Tech-
nical Appendix Table 2). S1 nuclease pulsed-field gel 
electrophoresis combined with bla
NDM-1
 probes detected 
bla
NDM-1
 on plasmids of limited size diversity in E. coli 
(ST101, 160 kb; ST405, 100 kb; ST648, 150 kb); how-
ever, other species included bla
NDM-1
–positive plasmids in 
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a wide diversity of sizes (30 kb–450 kb); some of these 
species had multiple positive plasmids, and bla
NDM-1
 was 
also found on the chromosome (online Technical Appen-
dix Table 1 and Figure 1).
The E. coli isolates were further analyzed by PCR to 
identify additional resistance mechanisms often associated 
with bla
NDM-1
 (Table). bla
CTX-M-15
 and 16s ribosomal meth-
ylase genes (armA or rmtB) were associated with most E. 
coli strains, which explains the extensively drug-resistant 
phenotype of the E. coli isolates (online Technical Ap-
pendix Table 3). Plasmids of plasmid incompatibility 
groups incFII (ST101, ST405, ST648) and incX (ST405, 
ST648) were also closely associated with E. coli strains 
(Table). E. coli harboring bla
NDM-1
 were isolated from 
10 sampling sites (Figure 1; online Technical Appendix 
Table 1). The E. coli isolates belonged to 3 different mul-
tilocus sequence typing groups: ST101 (phylogroup B1, 
20/53 samples); ST405 (phylogroup D, 5/53 samples); 
and ST648 (phylogroup D, 28/53 samples) (online Tech-
nical Appendix Table 2). ST101, which was found in 
samples from 6 (10.3%) of the 58 sites, was the most 
prevalent NDM-1–encoding E. coli genotype. ST648 rep-
resented an intermediate prevalence (5/58 [8.6%] sites), 
and ST405 was the least prevalent (1/58 [1.7%] sites) (on-
line Technical Appendix Tables 1, 2).
Conclusions
Our findings indicate that NDM-1 is widespread in the 
Dhaka environment. We detected 241 NDM-1–encod-
ing bacterial isolates; they were found in all 7 sampled 
regions and at 36 (62%) of the 58 sampling sites. This 
high level of environmental bla
NDM-1
 contamination is of 
concern, especially because drinking water in Bangladesh 
usually carries high levels of sewage-derived bacteria 
(11). It is therefore likely that bla
NDM-1
 carriage rates will 
rise rapidly. Future environmental studies could provide 
Figure 1.	Diversity	of	New-Delhi	metallo-β-lactamase	variant	1–encoding	species	and	the	number	found	in	58	locations	in	7	regions	
(red	circles	on	map)	of	Dhaka,	Bangladesh,	October	2012.	Individual	sampling	sites	were	within	2	km	of	each	sampling	region,	and	the	
number	of	sites	varied	from	6	to	12	per	region.	Pie	charts	indicate	the	proportions	of	different	blaNDM-1–positive bacteria isolated in each 
region;	colors	indicate	specific	species.	The	diameter	of	each	pie	chart	is	directly	proportional	to	the	number	of	blaNDM-1–positive isolates 
collected	in	each	region;	actual	numbers	are	shown	in	parentheses	after	the	region	name.	Numbers	within	pie	charts	indicate	the	
percentage of sites in each region in which the individual positive blaNDM-1–positive species were found. blaNDM-1 was detected in samples 
from	all	7	regions	and	from	36	(62%)	of	the	58	sampling	sites.
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indicators of epidemics of emerging resistant bacteria be-
fore they are realized in hospitals.
Despite the widespread presence of NDM-1 in Dhaka, 
it appears that this carbapenemase has recently emerged 
in the Bangladesh environment. Studies in northern Ban-
gladesh did not find NDM-1 in wild ducks and poultry in 
2009 (9) or in crow and gull feces in 2010 (10). Similarly, 
NDM-1 was not detected in drinking water in Dhaka during 
2008–2009 (11) even though all samples had high levels of 
fecal and bla
CTX-M-15
 contamination. Furthermore, a study 
of 1,879 clinical E. coli and Shigella spp. isolates collected 
during 2009–2010 in Bangladesh did not detect bla
NDM-1
 
(12). The first known clinical isolates date from 2008 (12), 
and the first evidence of human gut carriage of bla
NDM-1
 was 
found in samples collected in Dhaka (13) a month before 
our study.
Because E. coli is the leading cause of human uri-
nary tract infections, bloodstream infections, and neo-
natal meningitis, the ability of NDM-1 to give this bac-
terium clinical resistance to carbapenems is of concern 
(14). E. coli is also universally carried in the human gut. 
Therefore, we focused on this species because it is likely 
to be the greatest threat to human health. E. coli encoding 
NDM-1 were found in 3 of the 7 sampled regions, and 
genotyping showed they belonged to only 3 STs: ST648, 
ST101, and ST405. These same 3 E. coli genotypes are 
 
 
 
Table. Resistance	genes	and	plasmid	profiles	for	a	subset	of	Escherichia coli strains	in	a	study	of	extensively	drug-resistant	New	Delhi	
metallo-β-lactamase–encoding	bacteria	in	the	environment,	Dhaka,	Bangladesh,	October	2012* 
E. coli strain, ST 
Resistance genes 
blaCTX-M-15 blaNDM 16S	methylase blaampC incX incFII incL/M incA/C incN2 
18, ST101 + NDM-3 rmtB   +    
24,	ST101 + NDM-3 rmtB   +    
25,	ST101 + + rmtB   +    
28,	ST101 + NDM-3 rmtB   +    
221,	ST101 + NDM-1 rmtB   +    
34,	ST648 + + armA cmy, dha + +    
192,	ST648 + NDM-4 armA cmy, dha + +    
346,	ST648 + + armA cmy, dha + +    
43,	ST405 + NDM-1 armA cmy, dha + +    
54, ST405 + NDM-1 armA cmy, dha + +    
*armA and rmtB, aminoglycoside methylase genes;	CTX-M-15, cmy, and dha, -lactamases;	inc,	plasmid	incompatibility	group;	NDM,	New-Delhi metallo-
β-lactamase;	ST,	sequence	type;	,	negative;	+,	positive. 
 
Figure 2.	Sites	where	New-Delhi	metallo-β-lactamase	variant	1	(NDM-1)–encoding	Escherichia coli	sequence	type	(ST)	101	isolates	
have	been	detected	worldwide.	Stars	indicate	countries	where	NDM-encoding	E. coli	ST101	has	been	detected:	Australia,	Bangladesh,	
Belgium,	Bulgaria,	China,	Canada,	Denmark,	France,	Germany,	India,	Korea,	New	Zealand,	Pakistan,	the	United	Kingdom,	and	the	
United States.
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responsible for 80% of clinical NDM-1–encoding E. 
coli isolates in the United Kingdom (15). Furthermore, 
ST101 is the most common E. coli genotype in the Ban-
gladesh environment (10.3% prevalence) and in clinical 
isolates from the United Kingdom (50%). Results of a 
literature search for NDM-1–encoding E. coli belonging 
to ST101 showed that this genotype has been detected 
in 15 nations (Figure 2). Thus, E. coli ST101 appears 
to be a successful global genotype that is often associ-
ated with NDM-1. This association with a single global 
genotype is analogous to the association between E. coli 
ST131 and the cephalosporinase CTX-M-15. Because of 
the critical nature of extensively drug-resistant bacteria, 
we are investigating the underlying factors responsible 
for the success of these particular antimicrobial drug–re-
sistant strains.
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